548 related articles for article (PubMed ID: 18593850)
1. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
[TBL] [Abstract][Full Text] [Related]
2. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
Hirabara SM; Curi R; Maechler P
J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
[TBL] [Abstract][Full Text] [Related]
3. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
4. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
Dumas JF; Simard G; Flamment M; Ducluzeau PH; Ritz P
Diabetes Metab; 2009 Jun; 35(3):159-67. PubMed ID: 19349201
[TBL] [Abstract][Full Text] [Related]
5. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
[TBL] [Abstract][Full Text] [Related]
6. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
[TBL] [Abstract][Full Text] [Related]
7. Is mitochondrial dysfunction a cause of insulin resistance?
Turner N; Heilbronn LK
Trends Endocrinol Metab; 2008 Nov; 19(9):324-30. PubMed ID: 18804383
[TBL] [Abstract][Full Text] [Related]
8. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice.
Bonnard C; Durand A; Peyrol S; Chanseaume E; Chauvin MA; Morio B; Vidal H; Rieusset J
J Clin Invest; 2008 Feb; 118(2):789-800. PubMed ID: 18188455
[TBL] [Abstract][Full Text] [Related]
10. Free fatty acids and skeletal muscle insulin resistance.
Kraegen EW; Cooney GJ
Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent effects of fatty acids on skeletal muscle metabolism.
Hirabara SM; Silveira LR; Abdulkader F; Carvalho CR; Procopio J; Curi R
J Cell Physiol; 2007 Jan; 210(1):7-15. PubMed ID: 17013887
[TBL] [Abstract][Full Text] [Related]
12. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes mellitus and skeletal muscle metabolic function.
Phielix E; Mensink M
Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
[TBL] [Abstract][Full Text] [Related]
14. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
Noland RC; Woodlief TL; Whitfield BR; Manning SM; Evans JR; Dudek RW; Lust RM; Cortright RN
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E986-E1001. PubMed ID: 17638705
[TBL] [Abstract][Full Text] [Related]
15. Short-term increase of plasma free fatty acids does not interfere with intrinsic mitochondrial function in healthy young men.
Brands M; Hoeks J; Sauerwein HP; Ackermans MT; Ouwens M; Lammers NM; van der Plas MN; Schrauwen P; Groen AK; Serlie MJ
Metabolism; 2011 Oct; 60(10):1398-405. PubMed ID: 21489571
[TBL] [Abstract][Full Text] [Related]
16. Diet-induced modulation of mitochondrial activity in rat muscle.
Laurent D; Yerby B; Deacon R; Gao J
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1169-77. PubMed ID: 17711988
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
[TBL] [Abstract][Full Text] [Related]
18. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle.
Brehm A; Krssak M; Schmid AI; Nowotny P; Waldhäusl W; Roden M
Diabetes; 2006 Jan; 55(1):136-40. PubMed ID: 16380486
[TBL] [Abstract][Full Text] [Related]
19. Submicromolar concentrations of palmitoyl-CoA specifically thioesterify cysteine 244 in glyceraldehyde-3-phosphate dehydrogenase inhibiting enzyme activity: a novel mechanism potentially underlying fatty acid induced insulin resistance.
Yang J; Gibson B; Snider J; Jenkins CM; Han X; Gross RW
Biochemistry; 2005 Sep; 44(35):11903-12. PubMed ID: 16128592
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in obesity: metabolic mechanisms and measurement methods.
Belfiore F; Iannello S
Mol Genet Metab; 1998 Oct; 65(2):121-8. PubMed ID: 9787104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
